SBMJF (Dimerix) Interest Coverage: N/A (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SBMJF Dimerix Ltd SBMJF
22 GF Score
Price $0.35
! 3 Warning Signs
View Full Analysis

What is Dimerix Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Dimerix's Operating Income for the six months ended in Jun. 2026 was $-10.85 Mil. Dimerix's Interest Expense for the six months ended in Jun. 2026 was $0.00 Mil. GuruFocus does not calculate 's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Dimerix Ltd has enough cash to cover all of its debt. Its financial situation is stable.

The historical rank and industry rank for Dimerix's Interest Coverage or its related term are showing as below:

SBMJF' s Interest Coverage Range Over the Past 10 Years
Min: No Debt   Med: No Debt   Max: No Debt
Current: No Debt


SBMJF's Interest Coverage is ranked better than
98.93% of 373 companies
in the Biotechnology industry
Industry Median: 106.14 vs SBMJF: No Debt

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Dimerix  (OTCPK:SBMJF) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Dimerix Interest Coverage Related Terms


Dimerix Interest Coverage Historical Data

* Premium members only.

The historical data trend for Dimerix's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Dimerix Interest Coverage Chart

Dimerix Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
Interest Coverage
Get a 7-Day Free Trial Premium Member Only Premium Member Only N/A No Debt N/A No Debt N/A

Dimerix Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A N/A No Debt No Debt N/A

SBMJF vs VRTX, REGN, MRNA: Interest Coverage Comparison

For the Biotechnology subindustry, Dimerix's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dimerix Interest Coverage vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Dimerix's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Dimerix's Interest Coverage falls into.


SBMJF
22GF Score
Dimerix Ltd SBMJF
Interest Coverage is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dimerix Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Dimerix's Interest Coverage for the fiscal year that ended in Jun. 2026 is calculated as

Here, for the fiscal year that ended in Jun. 2026, Dimerix's Interest Expense was $0.00 Mil. Its Operating Income was $-26.13 Mil. And its Long-Term Debt & Capital Lease Obligation was $0.08 Mil.

GuruFocus does not calculate Dimerix's interest coverage with the available data.

Dimerix's Interest Coverage for the quarter that ended in Jun. 2026 is calculated as

Here, for the six months ended in Jun. 2026, Dimerix's Interest Expense was $0.00 Mil. Its Operating Income was $-10.85 Mil. And its Long-Term Debt & Capital Lease Obligation was $0.08 Mil.

GuruFocus does not calculate Dimerix's interest coverage with the available data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.


Dimerix Business Description

Other Exchanges DXB:Australia
Address 425 Smith Street, Fitzroy, VIC, AUS, 3065
Dimerix Ltd is a biopharmaceutical company developing new therapies in areas with unmet medical needs. The company is developing four product candidates: DMX-200 for FSGS; DMX-200 for diabetic kidney disease; DMX-200 for ARDS associated with COVID-19; and DMX-700 for COPD, as well as the proprietary ReceptorHIT assay technology. It pursues new product concepts and applies deep scientific knowledge to the discovery of products from early-stage development through to commercialisation. Dimerix products will target multiple territories. The Group has only operated in one Segment, being investment in research and development of biopharmaceutical drugs.
22GF Score

Get the complete analysis for SBMJF

Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.35
Price